Cardiometabolic Heal
Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care
June 24, 2024 10:48 ET | Cardiometabolic Health Congress
Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) -- The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care. The event will be held June...
Embecta_Logo.jpg
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
June 24, 2024 06:30 ET | Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir
Fractyl-Logo.png
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
June 24, 2024 06:00 ET | Fractyl Health, Inc.
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Afrezza (inhaled insulin) in use
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
June 22, 2024 08:00 ET | MannKind
INHALE-3 STUDY REVEALS POSITIVE READOUT IN HEAD-TO-HEAD COMPARISON OF INHALED INSULIN VS. USUAL CARE IN T1D; NEW DATA PRESENTED
SAB BIO Logo
SAb Biotherapeutics Rebrands as SAB BIO
June 20, 2024 07:20 ET | SAB Biotherapeutics, Inc.
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE...
GlucoModicum.png
Talisman needle-free CGM demonstrates strong correlation to blood glucose in clinical studies and moves towards large volume manufacturing
June 17, 2024 02:00 ET | GlucoModicum
Talisman needle-free CGM demonstrates strong correlation to blood glucose in clinical studies and moves towards large volume manufacturing Data from Clinical Performance Study of Talisman shows...
ADALVO LIMITED
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
June 13, 2024 06:38 ET | ADALVO LIMITED
Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.
Biosplice logo_final RGB 300 dpi_white background.png
Biosplice Announces Collaboration with Novo Nordisk in Diabetes
June 13, 2024 06:00 ET | Biosplice Therapeutics, Inc.
Biosplice enters into a pre-clinical collaboration with Novo Nordisk to develop inhibitors of DYRK for diabetes
logo.png
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
June 05, 2024 08:30 ET | GlucoTrack, Inc.
Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose monitor offers the potential for simplified, discreet...